Insider Transactions in Q4 2024 at Scholar Rock Holding Corp (SRRK)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 08
2024
|
Edward H Myles COO & CFO |
SELL
Open market or private sale
|
Direct |
37,187
-18.76%
|
$1,264,358
$34.9 P/Share
|
|
Oct 08
2024
|
Edward H Myles COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
37,187
+15.79%
|
$371,870
$10.0 P/Share
|
|
Oct 07
2024
|
Edward H Myles COO & CFO |
SELL
Open market or private sale
|
Direct |
206,240
-18.28%
|
$5,568,480
$27.19 P/Share
|
|
Oct 07
2024
|
Edward H Myles COO & CFO |
SELL
Exercise of conversion of derivative security
|
Direct |
206,240
-35.96%
|
$2,681,120
$13.83 P/Share
|
|
Oct 07
2024
|
Tracey Sacco CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
30,000
-19.6%
|
$750,000
$25.91 P/Share
|
|
Oct 07
2024
|
Tracey Sacco CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+27.45%
|
$300,000
$10.0 P/Share
|
|
Oct 07
2024
|
Srinivas Akkaraju |
SELL
Open market or private sale
|
Indirect |
1,175,713
-6.11%
|
$35,271,390
$30.0 P/Share
|
|
Oct 07
2024
|
Jing L. Marantz CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
109,375
-24.77%
|
$2,953,125
$27.29 P/Share
|
|
Oct 07
2024
|
Jing L. Marantz CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
109,375
+37.51%
|
$875,000
$8.59 P/Share
|